JANSSEN PHARMS FDA Approval NDA 020966

NDA 020966

JANSSEN PHARMS

FDA Drug Application

Application #020966

Documents

Letter1999-03-30
Letter2001-04-17
Letter2001-04-17
Letter2002-07-17
Letter2004-07-21
Letter2009-03-10
Letter2009-04-27
Label1999-03-30
Label2001-04-17
Label2009-04-03
Label2009-04-28
Review2001-10-26
Review2001-10-26
Letter2001-04-17
Letter2002-02-28
Letter2009-03-10
Letter2009-03-10
Label2001-04-17
Label2001-04-17
Label2002-07-17
Label2004-07-21
Label2009-04-03
Label2009-04-03
Review2003-08-13
Review2001-10-26

Application Sponsors

NDA 020966JANSSEN PHARMS

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION10MG/ML0SPORANOXITRACONAZOLE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1999-03-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1999-10-25STANDARD
LABELING; LabelingSUPPL3AP2001-05-09STANDARD
EFFICACY; EfficacySUPPL4AP2001-05-09STANDARD
LABELING; LabelingSUPPL5AP2002-02-28STANDARD
LABELING; LabelingSUPPL6AP2002-07-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2002-08-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2002-08-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-09-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP2002-10-10STANDARD
LABELING; LabelingSUPPL11AP2004-07-14STANDARD
LABELING; LabelingSUPPL17AP2009-03-05STANDARD
LABELING; LabelingSUPPL18AP2009-03-05STANDARD
LABELING; LabelingSUPPL20AP2009-03-05STANDARD
LABELING; LabelingSUPPL22AP2009-04-23STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL17Null0
SUPPL18Null0
SUPPL20Null0
SUPPL22Null0

CDER Filings

JANSSEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20966
            [companyName] => JANSSEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"SPORANOX","activeIngredients":"ITRACONAZOLE","strength":"10MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"04\/23\/2009","submission":"SUPPL-22","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020966s022lbl.pdf\"}]","notes":""},{"actionDate":"03\/05\/2009","submission":"SUPPL-20","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020966s017s018s020lbl.pdf\"}]","notes":""},{"actionDate":"03\/05\/2009","submission":"SUPPL-18","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020966s017s018s020lbl.pdf\"}]","notes":""},{"actionDate":"03\/05\/2009","submission":"SUPPL-17","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/020966s017s018s020lbl.pdf\"}]","notes":""},{"actionDate":"07\/14\/2004","submission":"SUPPL-11","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20966s011lbl.pdf\"}]","notes":""},{"actionDate":"07\/17\/2002","submission":"SUPPL-6","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/20966s6lbl.pdf\"}]","notes":""},{"actionDate":"05\/09\/2001","submission":"SUPPL-4","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2001\\\/20-966S001_Sporanox_prntlbl.pdf\"}]","notes":""},{"actionDate":"05\/09\/2001","submission":"SUPPL-3","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2001\\\/20-966S001_Sporanox_prntlbl.pdf\"}]","notes":""},{"actionDate":"05\/09\/2001","submission":"SUPPL-1","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2001\\\/20-966S001_Sporanox_prntlbl.pdf\"}]","notes":""},{"actionDate":"03\/30\/1999","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/1999\\\/20966lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"SPORANOX","submission":"ITRACONAZOLE","actionType":"10MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2009-04-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.